Explore breast cancer research in npj Breast Cancer, an open access journal with 6.5 Impact Factor and 7 days to first decision.
Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total...
Accessing the massive amount of breast cancer data that are currently publicly available may seem daunting to the brand new graduate student embarking on his/her first project or even to the seasoned lab leader, who may wish to explore a new avenue of in
Triple negative breast cancer (TNBC), which accounts for 15–20% of incident breast cancers, is the only breast cancer (BC) subtype that lacks targeted treatments. Using clinical assays, TNBC is human epidermal growth factor receptor 2 (HER2) negative and has <1% expression of estrogen receptor...
It is largely unknown how the development of breast cancer (BC) is transduced by somatic genetic alterations in the benign breast. Since benign breast disease is an established risk factor for BC, we established a case-control study of women with a histo
Npj Breast Cancer 9 Weeks审稿时间 2区中科院分区 Q1JCR分区 6.5影响因子 ISSN:2374-4677 E-ISSN:2374-4677 国际简称:NPJ BREAST CANCER 出版国家或地区:ENGLAND 研究方向:Medicine - Pharmacology (medical) 是否预警:否 创刊时间:2015 H-index:暂无数据 ...
20.Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer 机译:Honeybee Venom和Melittin抑制了Her2浓缩和三阴性乳腺癌中生长因子受体激活 作者:Ciara Duffy;Anabel Sorolla;Edina Wang;Emily Golden;Eleanor Woodward;Kathleen Davern;Diwei Ho;Elizab...
documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) ...
Fig. 1: Intrinsic molecular subtypes of breast cancer. Within each clinical subtype there are multiple molecular subtypes. ER endocrine receptor; TNBC triple negative breast cancer; HER2 Human Epidermal Growth Factor Receptor 2. Full size image ...
Prediction of 4-category molecular subtypes of breast cancer The results of different models in terms of the evaluation metrics for predicting 4-category molecular subtypes of breast cancer in the test cohort (n = 672) are displayed in Table 2. The Multi-ResNet50 model had an accuracy of...